<DOC>
	<DOCNO>NCT01123772</DOCNO>
	<brief_summary>The purpose study evaluate tolerable safe give INO-8875 eye drop different concentration normal old healthy adult volunteer two week .</brief_summary>
	<brief_title>Phase I Dose-Escalation Study Evaluate Tolerability , Safety &amp; PK INO-8875 Healthy Older-Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Adenosine</mesh_term>
	<criteria>male , female negative pregnancy test without childbearing potential age 35 65 year body weight ≥50 kg ≤115 kg Subject glaucoma active ophthalmologic disease include conjunctivitis Subject central retinal vein occlusion either eye time past Subject currently drug might affect IOP include oral ocular glucocorticoid ephedrine Subject history ocular trauma surgery ( except nonincisional surgery perform least 3 month prior Screening visit ) Subject prosthetic eye ocular abnormality preclude reliable applanation tonometry either eye include immobile pupil . Subject able refrain use contact lenses Treatment Period</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>adenosine agonist</keyword>
	<keyword>eye drop</keyword>
	<keyword>elderly volunteer</keyword>
	<keyword>old healthy volunteer</keyword>
</DOC>